Geo News
Community curated by people like you
LatestAICryptoHealthWorld AffairsUS Politics

BMJ stories

Oct 28, 2026

High-volume injections for Achilles tendinopathy show no benefit over placebo in clinical trial

A clinical trial published in The BMJ found that commonly used injections for Achilles tendinopathy—including high-volume saline, local anesthetic, and low-dose corticosteroid—offer no meaningful clinical advantage over sham treatment. The findings add to ongoing controversy about corticosteroid injections for tendon conditions.

Oct 28, 2026·3 sources
00
Aug 5, 2026

Study finds diabetes drug tirzepatide reduces heart attack and stroke risk in high-risk patients

New research published in The BMJ shows that tirzepatide (Mounjaro), a GLP-1 receptor agonist, reduces the risk of major cardiovascular events by 33% in type 2 diabetes patients with existing heart disease. A separate study also found that consistent medication adherence among diabetes patients reduces heart disease risk by 27%.

Aug 5, 2026·11 sources
00

Top claims

  • ▪In the clinical trial published in October 2026, high-volume injections without corticosteroid demonstrated no clinical benefit over sham injections at any measured time point up to 52 weeks.
  • ▪In the 2026 clinical trial, 16% of participants receiving high-volume injections without corticosteroid experienced aggravated Achilles pain.
  • ▪At 26 weeks post-treatment, participants receiving high-volume injections with corticosteroid reported significantly worse pain and disability outcomes than those receiving high-volume injections without corticosteroid.

Topics

Clinical trialsInjury rehabilitationRandomized controlled trialMusculoskeletal healthMedication adherenceCardiovascular health.GLP-1 medications